Abivax S.A.

ABVX.PA · PAR
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income-€101-€95-€82-€96
Dep. & Amort.€1€1€1€0
Deferred Tax€0€0€0€1
Stock-Based Comp.€11€0€11€8
Change in WC€2€14€4€12
Other Non-Cash€20€9-€20€26
Operating Cash Flow-€67-€70-€85-€70
Investing Activities
PP&E Inv.-€0-€0-€0-€0
Net Acquisitions€0€0€0€0
Inv. Purchases€0-€0-€0-€9
Inv. Sales/Matur.€0€0€0€1
Other Inv. Act.€1-€0€14€0
Investing Cash Flow€1-€1€13-€9
Financing Activities
Debt Repay.-€13-€5€43€0
Stock Issued€0€0€0€202
Stock Repurch.€0€0-€0€0
Dividends Paid€0€0€0€0
Other Fin. Act.€4-€3-€2€219
Financing Cash Flow-€9-€7€40€219
Forex Effect-€2€1€2-€5
Net Chg. in Cash-€43-€78-€30€138
Supplemental Information
Beg. Cash€104€222€252€114
End Cash€61€144€222€252
Free Cash Flow-€67-€71-€85-€70
Abivax S.A. (ABVX.PA) Financial Statements & Key Stats | AlphaPilot